Please login to the form below

Not currently logged in

Kantar Health adds to UK team

Group director, junior designers and graduate research team appointed

Global healthcare consulting firm Kantar Health has added five new recruits to its Epsom, UK-based team.

Hazel Haskayne joins the company as group director, having spent 15 years at TNS - which Kantar acquired in 2008 - most recently as technology director, heading up the qualitative research offering for the firm's technology clients.

Kantar has also appointed Jenny Maddock, who specialises in print design and illustration and joins its creative impact team as a junior designer, and three new members of its graduate research programme - Anna Tapson, Will Edgar and Rachel Dixon.

Tapson studied psychology at Leeds University and has extensive research experience; Edgar has a genetics degree from the University of Manchester and has worked at Boehringer Ingelheim; and Dixon studied biology at the University of Bristol before completing a graduate diploma in law.

Jim Needell, managing director of Kantar Health UK, said: "These most recent additions to our team are already providing great insights and support to our clients in the UK pharmaceutical and biotech industries. Hazel is renowned for her passion, innovative thinking and business-savvy approach that will help our clients better answer their business questions. 

“Jenny's recruitment reinforces the importance Kantar Health places on creativity and impactful deliverables in offering more value to clients. Finally, we're delighted once again to be recruiting three such talented graduates onto our Graduate Programme, and we hope to continue our recent successes as multiple winners of the BHBIA's Best Industry Newcomer Award."

20th October 2014

From: Marketing



Featured jobs

Subscribe to our email news alerts


Add my company

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

Digital health
The untapped potential to transform healthcare...
When is it time to rebrand?
The Biosimilar Challenge